Claims
- 1. A heterocyclic compound of the formula: ##STR26## in which A represents --S--, --SO-- or SO.sub.2 --, R.sub.3 represents hydrogen, alkyl or phenyl unsubstituted or substituted by halogen, alkyl, alkoxy or trifluoromethyl, and
- (a) X represents oxygen, sulphur, imino or hydroxyimino, p represents 0 or 1 and Y represents a radical of the formula: ##STR27## in which R.sub.1 and R.sub.2 both represent hydrogen, or R.sub.1 represents hydrogen and R.sub.2 represents hydroxyl or alkyl of 1 to 5 carbon atoms, which is substituted by a carboxyl, amino, alkylamino, dialkylamino, hydroxyalkylamino, morpholino or imidazolyl, or piperazin-1-yl radical (unsubstituted or substituted in the 4-position by alkyl, benzyl optionally substituted by halogen, alkyl, alkoxy or trifluoromethyl, or phenyl optionally substituted by halogen, alkyl, alkoxy or trifluoromethyl) or a piperidino or pyrrolidin-1-yl radical, or R.sub.2 represents phenyl substituted by one or more hydroxyl, carboxyl, amino, alkylamino or dialkylamino radicals, or R.sub.1 and R.sub.2 form, with the nitrogen atom to which they are bonded, a 5-membered or 6-membered ring which can also contain another heteroatom selected from oxygen, sulphur and nitrogen and which is unsubstituted or substituted by alkyl, alkoxycarbonyl, hydroxyalkyl, aminoalkyl, alkylaminoalkyl or dialkylaminoalkyl, a benzyl radical (optionally substituted by a halogen atom or an alkyl, alkoxy or trifluoromethyl radical) or a pyrrolidin-1-yl carbonylalkyl radical, or
- (b) X represents dialkylhydrazono, Y represents amino and p represents 0 or 1, or
- (c) X and Y form with the carbon atom to which they are bonded, a .DELTA.2-thiazolin-2-yl or .DELTA.2-imidazolin-2-yl radical and p represents 0 or 1, or
- (d) X represents oxygen, Y represents hydrogen and p is 0, the said alkyl radicals and alkyl portions being straight-chain or branched-chain and, unless stated otherwise, containing 1 to 4 carbon atoms each, and the tautomeric forms of the compounds where X represents imino, hydroxyimino or dialkylhydrazono and Y represents a radical of the formula (II) in which R.sub.1 represents a hydrogen atom, or where X represents oxygen or sulphur and Y represents a radical of the general formula (II) in which R.sub.1 represents hydrogen and R.sub.2 represents hydroxyl; and its addition salts with acids and, where they exist, its metal salts and its addition salts with nitrogen-containing bases.
- 2. A heterocyclic compound according to claim 1 in which A is --S--, --SO.sub.2 --, R.sub.3 is hydrogen, X is oxygen, sulphur, imino, or hydroxyimino, p is 0 or 1 and Y is a radical of formula: ##STR28## in which R.sub.1 and R.sub.2 are both hydrogen or R.sub.1 is hydrogen and R.sub.2 is hydroxy or dialkylaminoethyl, or R.sub.1 and R.sub.2 together with the nitrogen atom to which they are attached represent a saturated six-membered ring which may contain a second hetero-atom chosen from oxygen and nitrogen and which is unsubstituted or substituted by alkyl or benzyl, or X represents dialkylhydrazono, Y is amino, and p is 0, or the radical --C(:X)Y is .DELTA.2-thiazolin-2-yl or --CHO and p is 0.
- 3. A heterocyclic compound according to claim 1, in which A is --S--, or SO.sub.2 --, R.sub.3 is hydrogen, p is 0, X is oxygen, sulphur, or hydroxymino, and Y is amino, piperazin-1-yl, or 4-methyl-piperazin-1-yl, or X is dialkylhydrazono, and Y is amino.
- 4. A compound according to claim 1 which is 6-(pyridin-3-yl)-1,2-dihydro-4H-pyrrolo[1,2-c]-1,3-thiazine-8-carboxamide and its pharmaceutically acceptable salts.
- 5. A method for the prophylactic or therapeutic treatment of thrombosis which comprises administering to a subject in need of such treatment an effective amount of a compound according to claim 1 in the free form or in the form of an addition salt with a pharmaceutically acceptable acid or base.
- 6. A pharmaceutical composition useful for the prophylactic or therapeutic treatment of thrombosis comprising an effective amount of at least one compound according to claim 1, in the free form or in the form of an addition salt with a pharmaceutically acceptable acid or base, in association with one or more compatible pharmaceutically acceptable carriers.
Priority Claims (1)
Number |
Date |
Country |
Kind |
83 00454 |
Jan 1983 |
FRX |
|
Parent Case Info
This is a division of application Ser. No. 569,907 filed Jan. 11, 1984, now U.S. Pat. No. 4,546,100.
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
3294539 |
Bailey |
Dec 1966 |
|
Foreign Referenced Citations (2)
Number |
Date |
Country |
1401707 |
Apr 1965 |
FRX |
1069243 |
Jun 1967 |
GBX |
Divisions (1)
|
Number |
Date |
Country |
Parent |
569907 |
Jan 1984 |
|